Toll Free: 1-888-928-9744

Global Generic Drugs Market Size, Status and Forecast 2022

Published: Sep, 2017 | Pages: 117 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)

This report studies the global Generic Drugs market, analyzes and researches the Generic Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

•	Teva Pharma
•	Novartis-Sandoz
•	Mylan
•	Sun Pharmaceutical
•	Aspen Pharmacare
•	Allergan
•	Fresenius Kabi
•	Pfizer (Hospira)
•	Sanofi
•	Aurobindo
•	Lupin
•	Dr. Reddy's Lab
•	Apotex
•	Cipla
•	ENDO (Par Pharmaceutical)
•	Stada
•	Krka Group
•	Nichi-Iko Pharmaceutical
•	Valeant
•	Zydus Cadila
•	Hikma

Market segment by Regions/Countries, this report covers

•	United States
•	EU
•	Japan
•	China
•	India
•	Southeast Asia

Market segment by Type, Generic Drugs can be split into

•	Simple Generic Drugs
•	Super Generic Drugs
•	Biosimilars

Market segment by Application, Generic Drugs can be split into

•	CNS
•	Cardiovascular
•	Genitourinary/Hormonal Drugs
•	Respiratory
•	Rheumatology
•	Diabetes
•	Oncology
•	Others

If you have any special requirements, please let us know and we will offer you the report as you want.
 Table of Contents

Global Generic Drugs Market Size, Status and Forecast 2022

1 Industry Overview of Generic Drugs
    1.1  Generic Drugs Market Overview
        1.1.1 Generic Drugs Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Generic Drugs Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Generic Drugs Market by Type
        1.3.1 Simple Generic Drugs
        1.3.2 Super Generic Drugs
        1.3.3 Biosimilars
    1.4 Generic Drugs Market by End Users/Application
        1.4.1 CNS
        1.4.2 Cardiovascular
        1.4.3 Genitourinary/Hormonal Drugs
        1.4.4 Respiratory
        1.4.5 Rheumatology
        1.4.6 Diabetes
        1.4.7 Oncology
        1.4.8 Others

2 Global Generic Drugs Competition Analysis by Players
    2.1 Generic Drugs Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Teva Pharma
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Generic Drugs Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Novartis-Sandoz
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Generic Drugs Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Mylan
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Generic Drugs Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Sun Pharmaceutical
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Generic Drugs Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Aspen Pharmacare
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Generic Drugs Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Allergan
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Generic Drugs Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Fresenius Kabi
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Generic Drugs Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Pfizer (Hospira)
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Generic Drugs Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Sanofi
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Generic Drugs Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Aurobindo
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Generic Drugs Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Lupin
    3.12 Dr. Reddy's Lab
    3.13 Apotex
    3.14 Cipla
    3.15 ENDO (Par Pharmaceutical)
    3.16 Stada
    3.17 Krka Group
    3.18 Nichi-Iko Pharmaceutical
    3.19 Valeant
    3.20 Zydus Cadila
    3.21 Hikma

4 Global Generic Drugs Market Size by Type and Application (2012-2017)
    4.1 Global Generic Drugs Market Size by Type (2012-2017)
    4.2 Global Generic Drugs Market Size by Application (2012-2017)
    4.3 Potential Application of Generic Drugs in Future
    4.4 Top Consumer/End Users of Generic Drugs

5 United States Generic Drugs Development Status and Outlook
    5.1 United States Generic Drugs Market Size (2012-2017)
    5.2 United States Generic Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU Generic Drugs Development Status and Outlook
    6.1 EU Generic Drugs Market Size (2012-2017)
    6.2 EU Generic Drugs Market Size and Market Share by Players (2016 and 2017)

7 Japan Generic Drugs Development Status and Outlook
    7.1 Japan Generic Drugs Market Size (2012-2017)
    7.2 Japan Generic Drugs Market Size and Market Share by Players (2016 and 2017)

8 China Generic Drugs Development Status and Outlook
    8.1 China Generic Drugs Market Size (2012-2017)
    8.2 China Generic Drugs Market Size and Market Share by Players (2016 and 2017)

9 India Generic Drugs Development Status and Outlook
    9.1 India Generic Drugs Market Size (2012-2017)
    9.2 India Generic Drugs Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Generic Drugs Development Status and Outlook
    10.1 Southeast Asia Generic Drugs Market Size (2012-2017)
    10.2 Southeast Asia Generic Drugs Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Generic Drugs Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Generic Drugs Revenue and Growth Rate (2017-2022)
        11.1.2 EU Generic Drugs Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Generic Drugs Revenue and Growth Rate (2017-2022)
        11.1.4 China Generic Drugs Revenue and Growth Rate (2017-2022)
        11.1.5 India Generic Drugs Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Generic Drugs Revenue and Growth Rate (2017-2022)
    11.2 Global Generic Drugs Market Size (Value) by Type (2017-2022)
    11.3 Global Generic Drugs Market Size by Application (2017-2022)

12 Generic Drugs Market Dynamics
    12.1 Generic Drugs Market Opportunities
    12.2 Generic Drugs Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Generic Drugs Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Generic Drugs Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source
List of Tables and Figures

    Figure Generic Drugs Product Scope
    Figure Global Generic Drugs Market Size (Million USD) (2012-2017)
    Table Global Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Generic Drugs Market Share by Regions in 2016
    Figure United States Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure EU Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Japan Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure China Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure India Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Southeast Asia Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Generic Drugs Market Share by Type in 2016
    Figure Simple Generic Drugs Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Super Generic Drugs Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Biosimilars Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Global Generic Drugs Market Share by Application in 2016
    Table Key Downstream Customer in CNS
    Figure Generic Drugs Market Size (Million USD) and Growth Rate in CNS (2012-2017)
    Table Key Downstream Customer in Cardiovascular
    Figure Generic Drugs Market Size (Million USD) and Growth Rate in Cardiovascular (2012-2017)
    Table Key Downstream Customer in Genitourinary/Hormonal Drugs
    Figure Generic Drugs Market Size (Million USD) and Growth Rate in Genitourinary/Hormonal Drugs (2012-2017)
    Table Key Downstream Customer in Respiratory
    Figure Generic Drugs Market Size (Million USD) and Growth Rate in Respiratory (2012-2017)
    Table Key Downstream Customer in Rheumatology
    Figure Generic Drugs Market Size (Million USD) and Growth Rate in Rheumatology (2012-2017)
    Table Key Downstream Customer in Diabetes
    Figure Generic Drugs Market Size (Million USD) and Growth Rate in Diabetes (2012-2017)
    Table Key Downstream Customer in Oncology
    Figure Generic Drugs Market Size (Million USD) and Growth Rate in Oncology (2012-2017)
    Table Key Downstream Customer in Others
    Figure Generic Drugs Market Size (Million USD) and Growth Rate in Others (2012-2017)
    Table Generic Drugs Market Size (Million USD) by Players (2016 and 2017)
    Figure Generic Drugs Market Size Share by Players in 2016
    Figure Generic Drugs Market Size Share by Players in 2017
    Table Teva Pharma Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Teva Pharma (2012-2017)
    Figure Teva Pharma Generic Drugs Business Revenue Market Share in 2016
    Table Novartis-Sandoz Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Novartis-Sandoz (2012-2017)
    Figure Novartis-Sandoz Generic Drugs Business Revenue Market Share in 2016
    Table Mylan Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Mylan (2012-2017)
    Figure Mylan Generic Drugs Business Revenue Market Share in 2016
    Table Sun Pharmaceutical Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Sun Pharmaceutical (2012-2017)
    Figure Sun Pharmaceutical Generic Drugs Business Revenue Market Share in 2016
    Table Aspen Pharmacare Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Aspen Pharmacare (2012-2017)
    Figure Aspen Pharmacare Generic Drugs Business Revenue Market Share in 2016
    Table Allergan Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Allergan (2012-2017)
    Figure Allergan Generic Drugs Business Revenue Market Share in 2016
    Table Fresenius Kabi Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Fresenius Kabi (2012-2017)
    Figure Fresenius Kabi Generic Drugs Business Revenue Market Share in 2016
    Table Pfizer (Hospira) Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Pfizer (Hospira) (2012-2017)
    Figure Pfizer (Hospira) Generic Drugs Business Revenue Market Share in 2016
    Table Sanofi Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Sanofi (2012-2017)
    Figure Sanofi Generic Drugs Business Revenue Market Share in 2016
    Table Aurobindo Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Aurobindo (2012-2017)
    Figure Aurobindo Generic Drugs Business Revenue Market Share in 2016
    Table Lupin Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Lupin (2012-2017)
    Figure Lupin Generic Drugs Business Revenue Market Share in 2016
    Table Dr. Reddy's Lab Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Dr. Reddy's Lab (2012-2017)
    Figure Dr. Reddy's Lab Generic Drugs Business Revenue Market Share in 2016
    Table Apotex Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Apotex (2012-2017)
    Figure Apotex Generic Drugs Business Revenue Market Share in 2016
    Table Cipla Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Cipla (2012-2017)
    Figure Cipla Generic Drugs Business Revenue Market Share in 2016
    Table ENDO (Par Pharmaceutical) Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of ENDO (Par Pharmaceutical) (2012-2017)
    Figure ENDO (Par Pharmaceutical) Generic Drugs Business Revenue Market Share in 2016
    Table Stada Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Stada (2012-2017)
    Figure Stada Generic Drugs Business Revenue Market Share in 2016
    Table Krka Group Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Krka Group (2012-2017)
    Figure Krka Group Generic Drugs Business Revenue Market Share in 2016
    Table Nichi-Iko Pharmaceutical Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Nichi-Iko Pharmaceutical (2012-2017)
    Figure Nichi-Iko Pharmaceutical Generic Drugs Business Revenue Market Share in 2016
    Table Valeant Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Valeant (2012-2017)
    Figure Valeant Generic Drugs Business Revenue Market Share in 2016
    Table Zydus Cadila Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Zydus Cadila (2012-2017)
    Figure Zydus Cadila Generic Drugs Business Revenue Market Share in 2016
    Table Hikma Basic Information List
    Table Generic Drugs Business Revenue (Million USD) of Hikma (2012-2017)
    Figure Hikma Generic Drugs Business Revenue Market Share in 2016
    Table Global Generic Drugs Market Size (Million USD) by Type (2012-2017)
    Figure Global Generic Drugs Market Size Share by Type in 2012
    Figure Global Generic Drugs Market Size Share by Type in 2013
    Figure Global Generic Drugs Market Size Share by Type in 2014
    Figure Global Generic Drugs Market Size Share by Type in 2015
    Figure Global Generic Drugs Market Size Share by Type in 2016
    Figure Global Generic Drugs Market Size Share by Type in 2017
    Table Global Generic Drugs Market Size (Million USD) by Application (2012-2017)
    Figure Global Generic Drugs Market Size (Million USD) by Application in 2012
    Figure Global Generic Drugs Market Size (Million USD) by Application in 2013
    Figure Global Generic Drugs Market Size (Million USD) by Application in 2014
    Figure Global Generic Drugs Market Size (Million USD) by Application in 2015
    Figure Global Generic Drugs Market Size (Million USD) by Application in 2016
    Figure Global Generic Drugs Market Size (Million USD) by Application in 2017
    Table Top Consumer/End Users of Generic Drugs
    Figure United States Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table United States Generic Drugs Market Size (Million USD) by Players (2012-2017)
    Figure United States Generic Drugs Market Size Share by Players in 2016
    Figure United States Generic Drugs Market Size Share by Players in 2017
    Figure EU Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table EU Generic Drugs Market Size (Million USD) by Players (2012-2017)
    Figure EU Generic Drugs Market Size Share by Players in 2016
    Figure EU Generic Drugs Market Size Share by Players in 2017
    Figure Japan Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Japan Generic Drugs Market Size (Million USD) by Players (2012-2017)
    Figure Japan Generic Drugs Market Size Share by Players in 2016
    Figure Japan Generic Drugs Market Size Share by Players in 2017
    Figure China Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table China Generic Drugs Market Size (Million USD) by Players (2012-2017)
    Figure China Generic Drugs Market Size Share by Players in 2016
    Figure China Generic Drugs Market Size Share by Players in 2017
    Figure India Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table India Generic Drugs Market Size (Million USD) by Players (2012-2017)
    Figure India Generic Drugs Market Size Share by Players in 2016
    Figure India Generic Drugs Market Size Share by Players in 2017
    Figure Southeast Asia Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Southeast Asia Generic Drugs Market Size (Million USD) by Players (2012-2017)
    Figure Southeast Asia Generic Drugs Market Size Share by Players in 2016
    Figure Southeast Asia Generic Drugs Market Size Share by Players in 2017
    Figure Global Generic Drugs Market Size (Million USD) by Regions (2017-2022)
    Table Global Generic Drugs Market Size (Million USD) by Regions (2017-2022)
    Figure Global Generic Drugs Market Size Share by Regions in 2017
    Figure Global Generic Drugs Market Size Share by Regions in 2022
    Figure United States Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure EU Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Japan Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure China Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure India Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Southeast Asia Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Table Global Generic Drugs Market Size (Million USD) by Type (2017-2022)
    Figure Global Generic Drugs Market Size Share by Type in 2017
    Figure Global Generic Drugs Market Size Share by Type in 2022
    Table Global Generic Drugs Market Size (Million USD) by Application (2017-2022)
    Figure Global Generic Drugs Market Size (Million USD) by Application in 2017
    Figure Global Generic Drugs Market Size (Million USD) by Application in 2022 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $3300
Multi User - US $6600
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify